Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma

Oncology Research

Volumn 16, Issue 6, 2006, Pages 261-272

  Yi, Hong Mei ^a,b   Li, Hui ^a   Peng, Dan ^a   Zhang, He Jun ^a   Wang, Lei ^a   Zhao, Ming ^a   Yao, Kai Tai ^a   Ren, Cai Ping ^a  

^a Central South University   (China)

^b Hunan Province People's Hospital   (China)

Author keywords

Lactotransferrin; Loss of heterozygosity (LOH); Methylation; Mutation; Nasopharyngeal carcinoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GENOMIC DNA; LACTOFERRIN;

ADULT; ARTICLE; CHROMOSOME 3P; CLINICAL FEATURE; CONTROLLED STUDY; CPG ISLAND; DNA EXTRACTION; DNA SEQUENCE; EPIGENETICS; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METHYLATION; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOPHARYNGITIS;

EID: 34147114342     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783981008     Document Type: Article

References (32)

1. Yu, M. C.; Garabrant, D. H.; Huang, T. B.; Henderson, B. E. Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int. J. Cancer 45:1033-1039; 1990.
2. Lu, S. J.; Day, N. E.; Degos, L.; Lepage, V.; Wang, P. C.; Chan, S. H.; Simons, M.; McKnight, B.; Easton, D.; Zeng, Y. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 346:470-471; 1990.
3. Spruck, C. H.; Tsai, Y. C.; Huang, D. P.; Yang, A. S.; Rideout, W. M.; Gonzalez-Zulueta, M.; Choi, P.; Lo, K. W.; Yu, M. C.; Jones, P. A. Absence of p53 gene mutation in primary nasopharyngeal carcinomas. Cancer Res. 52:4787-4790; 1992.
4. Sun, Y.; Hegamyer, G.; Colburn, N. H. Nasopharyngeal carcinoma shows not detectable retinoblastoma susceptibility gene alterations. Oncogene 8:791-795; 1993.
5. Sun, Y.; Hildesheim, A.; Li, H.; Li, Y.; Chen, J. Y.; Cheng, Y. J.; Hayes, R. B.; Rothman, N.; Bi, W. F.; Cao, Y. No point mutation but a codon 31ser>arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): The polymorphism distinguishes Caucasians from Chinese. Cancer Epidemiol. Biomarkers Prev. 4:261-267; 1995.
6. Sun, Y.; Hildesheim, A.; Lanier, A. E.; Cao, Y.; Yao, K. T.; Raab-Traub, N.; Yang, C. S. No mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas. Oncogene 10:785-788; 1995.
7. Sun, Y.; Hildesheim, A.; Li, H.; Lanier, A. P.; Cao, Y.; Yao, K. T.; Yang, C. S.; Colburn, N. H. The von Hippel-Lindau (VHL) disease tumor-suppressor gene is not mutated in nasopharyngeal carcinoma. Int. J. Cancer 61:437-438; 1995.
8. Huang, D. P.; Lo, K. W.; Choi, P. H.; Ng, A. Y.; Tsao, S. Y.; Yiu, G. K.; Lee, J. C. Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genet. Cytogenet. 54:91-99; 1991.
9. Hui, A. B.; Lo, K. W.; Leung, S. F.; Teo, P.; Fung, M. K.; To, K. F.; Wong, N.; Choi, P. H.; Lee, J. C.; Huang, D. P. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridization. Int. J. Cancer 82:498-503; 1999.
10. Chan, A. S.; To, K. F.; Lo, K. W.; Mak, K. F.; Pak, W.; Chiu, B.; Tse, G. M.; Ding, M.; Li, X.; Lee, J. C.; Huang, D. P. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res. 60:5365-5370; 2000.
11. Deng, L.; Jing, N.; Tan, G.; Zhou, M.; Zhan, F., Xie, Y.; Cao, L.; Li, G. A common region of allelic loss on chromosome region 3p25.3-26.3 in nasopharyngeal carcinoma. Genes Chromosomes Cancer 23:21-25; 1998.
12. Cheng, Y.; Poulos, N. E.; Lung, M. L.; Hampton, G.; Ou, B.; Lerman, M. I.; Stanbridge, E. J. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc. Natl. Acad. Sci. USA 95:3042-3047; 1998.
13. Szeles, A.; Yang, Y.; Sandlund, A. M.; Kholodnyuk, I.; Kiss, H.; Kost-Alimova, M.; Zabarovsky, E. R.; Stanbridge, E.; Klein, G.; Imreh, S. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM. Genes Chromosomes Cancer 20:329-336; 1997.
14. Klintworth, G. K.; Sommer, J. R.; Obrian, G.; Han, L.; Ahmed, M. N.; Qumsiyeh, M. B.; Lin, P. Y.; Basti, S.; Reddy, M. K.; Kanai, A.; Hotta, Y.; Sugar, J.; Kumaramanickavel, G.; Murder, F.; Schorderet, D. F.; El Matri, L.; Iwata, F.; Kaiser-Kupfer, M.; Nagata, M.; Nakayasu, K.; Hejtmancik, J. F.; Teng, C. T. Familial subepithelial corneal amyloidosis (gelatinous drop-like corneal dystrophy): exclusion of linkage to lactoferrin gene. Mol. Vis. 4:31; 1998.
15. Yang, Y.; Kiss, H.; Kost-Alimova, M.; Kedra, D.; Fransson, I.; Seroussi, E.; Li, J.; Szeles, A.; Kholodnyuk, I.; Imreh, M. P.; Fodor, K.; Hadlaczky, G.; Klein, G.; Dumanski, J. P.; Imreh, S. A 1-Mb PAC contig spanning the common eliminated region 1 (CER1) in microcell hybrid-derived SCID tumors. Genomics 62:147-155; 1999.
16. Finkbeiner, W. E.; Carrier, S. D.; Teresi, C. E. Reverse transcription-polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands, and lung carcinomas. Am. J. Respir. Cell. Mol. Biol. 9:547-556; 1993.
17. Iijima, H.; Tomizawa, Y.; Iwasaki, Y.; Sato, K.; Sunaga, N.; Dobashi, K.; Saito, R.; Nakajima, T.; Minna, J. D. Mori, M. Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers. Int. J. Cancer 118:797-801 2006.
18. Penco, S.; Caligo, M. A.; Cipollini, G.; Bevilacqua, G. Garre, C. Lactoferrin expression in human breast cancer. Cancer Biochem. Biophys. 17:163-178; 1999.
19. Lee, J. Y.; Eom, E. M.; Kim, D. S.; Ha-Lee, Y. M.; Lee, D. H. Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE. Genomics 82:78-85; 2003.
20. Tuccari, G.; Giuffre, G.; Crisafulli, C.; Barresi, G. Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas. Eur. J. Histochem. 43:317-322; 1999.
21. Bezault, J.; Bhimani, R.; Wiprovnick, J.; Furmanski, P. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res. 54:2310-2312; 1994.
22. Damiens, E.; El Yazidi, I.; Mazurier, J.; Duthille, I.; Spik, G.; Boilly-Marer, Y. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J. Cell Biochem. 74:486-498; 1999.
23. Zhang, L.; Song, L.; Ma, Y.; Huang, B.; Liang, Q.; Zeng, Y. Differentially expressed gene in nasopharyngeal carcinoma cell lines with various metastatic potentialities. Zhonghua Zhong Liu Za Zhi 24:430-434; 2002.
24. Sambrool, J.; Fritsch, E. F.; Maniatis, T. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
25. Peng, D.; Ren, C.; Yi, H.; Zhou, L.; Yang, X.; Li, H.; Yao, K. Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim. Biophys. Sin. 38:349-355; 2006.
26. Wong, C. M.; Lee, J. M.; Clung, Y. P.; Jin, D. Y.; Ng, I. O. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res. 63:7646-7651; 2003.
27. Zhou, L.; Jiang, W.; Ren, C.; Yin, Z.; Feng, X.; Liu, W.; Tao, Q.; Yao, K. Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. Neoplasia 7:809-815; 2005.
28. Chow, L. S.; Lo, K. W.; Kwong, J.; To, K. F.; Tsang, K. S.; Lam, C. W.; Dammann, R.; Huang, D. P. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int. J. Cancer 109:839-847; 2004.
29. Liu, X. Q.; Chen, H. K.; Zhang, X. S.; Pan, Z. G.; Li, A.; Feng, Q. S.; Long, Q. X.; Wang, X. Z.; Zeng, Y. X. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int. J. Cancer 106:60-65; 2003.
30. Qiu, G. H.; Tan, L. K.; Loh, K. S.; Lim, C. Y.; Srivastava, G.; Tsai, S. T.; Tsao, S. W.; Tao, Q. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 23:4793-4806; 2004.
31. Yang, Y.; Li, J.; Szeles, A.; Imreh, M. P.; Kost-Alimova, M.; Kiss, H.; Kholodnyuk, I.; Fedorova, L.; Darai, E.; Klein, G.; Imreh, S. Consistent downregulation of human lactoferrin gene, in the common eliminated region 1 on 3p21.3, following tumor growth in severe combined immunodeficient (SCID) mice. Cancer Lett. 191:155-164; 2003.
32. Teng, C.; Gladwell, W.; Raphiou, I.; Liu, E. Methylation and expression of the lactoferrin gene in human tissues and cancer cells. Biometals 17:317-323; 2004.